Table 4.
Study | Study description/Population | Hospitalization rate | Average duration of stay |
---|---|---|---|
Turkey | |||
Dinleyici 201215 | VARICOMP: Children between age 0–15 y hospitalized due to varicella, October 2008 to September 2010 | Overall estimated incidence of varicella-related hospitalization: 5.3–6.9 per 100,000 children per year |
6 d (median) 11 d in ICU (median) |
Dinleyici 201510 | VARICOMP: Children between age 0–15 y hospitalized due to breakthrough varicella, October 2008 to September 2013 | NR | 8 d (median) |
Dinleyici 2016*67 | VARICOMP: Varicella-related hospitalization among children aged 1–5 y Pre-UVV era Post-UVV era |
6.1–9.1 per 100,000 children per year 3.1–4.3 per 100,000 children per year |
NR |
Turel 201364 | Study of 186 patients hospitalized with varicella, November 2006 to June 2011 | 74.2% of patients were aged < 3 y, of which 64.2% were ≤ 1 y | 5 d (median) |
Kurugol 201114 | Study of 466 cases of breakthrough varicella in vaccinated children, and 723 cases of varicella in unvaccinated children | 0.2% of children in the vaccinated group and 0.6% in the unvaccinated group | NR |
Koturoglu 200563 | Study of 178 cases in children between 2007 and 2011 | NR | 6.2 d (mean) |
UAE | |||
Uduman24 | 187 hospitalized during 2000–2004 (pre-UVV era) | NR | 7.5 d (mean) |
Abro 200962 | Study period March 2005 to February 2008 (pre-UVV era) | NR | 7.45 d (mean) |
Saudi Arabia | |||
Almuneef 200621 | Data collection period June 1, 2001, to December 30, 2003 (Pre-UVV era) | Hospitalization rate due to varicella: 2,050 per 100,000 reported cases |
NR |
ICU, intensive care unit; NR, not reported; UVV, universal varicella vaccine.
*Denotes gray data.